← Back to Search

Behavioral Intervention

Participants for Drug Overdose

N/A
Waitlist Available
Led By Katherine Rittenbach, PhD
Research Sponsored by AHS Cancer Control Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

To help prevent deaths in populations that cannot or will not access physical safer consumption services in Alberta, which may disproportionately include women and those who are not able to self-inject (Potier et al., 2014) the investigators propose to provide virtual (phone-based) supervised consumption services, staffed by people with lived experience.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Usage
Secondary outcome measures
EMS dispatch outcome
EMS response time
Other outcome measures
Health care usage
Length of calls
Proportion of calls for which EMS is dispatched
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: ParticipantsExperimental Treatment1 Intervention
All participants will be given the phone number and encouraged to call any time they plan to use substances alone

Find a Location

Who is running the clinical trial?

AHS Addiction and Mental Health Strategic Clinical NetworkUNKNOWN
TELUSUNKNOWN
2 Previous Clinical Trials
366 Total Patients Enrolled
AHS Cancer Control AlbertaLead Sponsor
182 Previous Clinical Trials
36,212 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby May 2025